Interleukin-1 receptor antagonist eye drops promoting high-risk corneal allografts survival in rats

Chinese Medical Journal

Volumn 117, Issue 5, 2004, Pages 711-716

  Jie, Ying ^a   Zhang, Wen Hua ^a   Pan, Zhi Qiang ^a   Wu, Yu Ying ^a   Wang, Ying ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Allograft rejection; CD1; Corneal transplantation; Interleukin 1 receptor antagonist

Indexed keywords

CD1 ANTIGEN; EYE DROPS; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SUTURE MATERIAL;

ACUTE GRAFT REJECTION; ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORNEA TRANSPLANTATION; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; RAT; RAT STRAIN; RECIPIENT; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SUTURING METHOD; TIME;

ANIMALS; ANTIGENS, CD1; CORNEA; CORNEAL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; OPHTHALMIC SOLUTIONS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RISK; SIALOGLYCOPROTEINS; TRANSPLANTATION, HOMOLOGOUS;

EID: 2942627614     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Williams KA, Roder D, Esterman A, et al. Factors predictive of corneal graft survival: report from the Australian corneal graft registry. Ophthalmology 1992;99:403-414.
2. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol 1990;48:191-226.
3. Streilein JW. Immunologic non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye. Eye 1995;9:236-240.
4. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal tranplantation studies. Ophthalmology 1994;101:1536-1547.
5. Williams KA, Muehiberg SM, Lewis RF, et al. How successful is corneal transplantation? A report from the Australian corneal graft register. Eye 1995;9:219-227.
6. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularezation. Invest Ophthalmol Vis Sci 1996;37:2485-2494.
7. Raizman M. Corticosteroid therapy of eye disease: fifty years later. Arch Ophthalmol 1996;114:1000-1001.
8. Frangie JP, Leibowitz HM. Steroids. Int Ophthalmol Clin 1993;33:9-29.
9. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. New Eng J Med 1993;328:106-113.
10. Kijlstra A. The role of cytokines in ocular inflammation. Br J Ophthalmol 1994;78:885-886.
11. Dana MR, Zhu SN, Yamada J. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 1998;17:403-409.
12. Hannumn CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990;343:336-340.
13. Antin JH, Weinstein HJ, Guinan EC, et al. Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. Blood 1994;84: 1342-1348.
14. Yamada J, Dana MR, Zhu SN, et al. Interleukin-1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch Ophthalmol 1998;116:1351-1357.
15. Dana MR, Dai R, Zhu SN, et al. Interleukin-1 receptor antagonist suppresses langerhans cell activity and promotes ocular immune privilege. Invest Ophthalmol Vis Sci 1998;39: 70-77.
16. Williams KA, Coster DJ. Penetrating cornea transplantation in the inbred rat: a new model. Invest Ophthalmol Vis Sci 1985;26:23-30.
17. Holland EJ, Chan CC, Wetzig RP, et al. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Corneal 1991;10:374-380.
18. Gebhardt BM, Varnell ED, Kaufman HE. Cyclosporine in collagen particle: corneal penetration and suppression of allograft rejection. J Ocul Pharmacol Ther 1995;11:509-517.
19. Mills RA, Jones DB, Winkler CR, et al. Topical FK-506 prevents experimental corneal allografts rejection. Corneal 1995;14:157-160.
20. Ma D, Mellon J, Niederkorn JY. Oral immunization as a strategy for enhancing corneal allograft survival. Br J Ophthalmol 1997;81:778-784.
21. Dana MR, Yamada J, Streilein JW. Topical interleunkin-1 receptor antagonist promotes corneal transplant survival. Transplantation 1997;63:1501-1507.
22. 1 and class I MHC antigen by human thymocytes. J Immunol 1989;142:2714-2720.
23. 1 molecule expressed in dendritic cells. J Biol Chem 2000;275:37757-37764.
24. 1 molecules. J Immunol 1998;160:3128-3134.
25. 1 molecules: nowhere for intracellular pathogens to hide. Traffic 2000;1:295-300.
26. Lucia K, Vladimir H, Lynne L, et al. Cell subpopulations in failed human cormeal grafts. Br J Ophthalmol 1999;83:1364-1369.